Sort
50,496 grants matching “lung cancer”
TCR signaling and cell cycle regulation in tumor-specific CD8 T cell dysfunction
$523,449Mary Philip · Vanderbilt University Medical Center · R37 · FY2024 · CA
Optimizing Lung Cancer Treatment in HIV Infected Persons
$523,421Keith Magnus Sigel · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Functional Studies of Candidate Lung Cancer Susceptibility Genes
$523,418Christopher I. Amos · Dartmouth College · U19 · FY2013 · CA
Radon on the RADAR
$523,341Ellen J Hahn · University Of Kentucky · R01 · FY2023 · ES
Randomized Trial of Stepped Palliative Care versus Early Integrated Palliative Care in Patients with Advanced Lung Cancer
$523,338Jennifer Temel · Massachusetts General Hospital · R01 · FY2018 · CA
Identifying the pro-metastatic mechanisms of neutrophil extracellular traps
$523,272Mikala Egeblad · Cold Spring Harbor Laboratory · R01 · FY2022 · CA
Understanding how elevated triglycerides contribute to triple negative breast cancer growth and metastasis
$523,192Emily Jane Gallagher · Icahn School Of Medicine At Mount Sinai · R37 · FY2022 · CA
Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis
$523,158Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Lung Cancer Chemoradiation: Predictors of Survival
$523,158Xifeng Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA
Role of IKK alpha in lung cancer development
$523,158Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Toward precision radiotherapy: Physiological modeling of respiratory motion based on ultra-quality 4D-MRI
$523,151G. Wilson Miller · University Of Virginia · R01 · FY2021 · CA
Studies of Occupational Cancer
$523,142Qing Lan · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS
$523,113University Of California Los Angeles · U01 · FY2004 · CA
Care coordination for complex cancer survivors in an integrated safety-net system
$523,019Simon J. Craddock Lee · Ut Southwestern Medical Center · R01 · FY2016 · CA
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis
$523,014Stephen Tc Wong · Methodist Hospital Research Institute · U01 · FY2023 · CA
S100A4 Regulation of IPF Mesenchymal Progenitor Cell Fibrogenicity
$522,986Craig A Henke · University Of Minnesota · R01 · FY2022 · HL
Nutritional & Behavioral Cancer Prevention in a Multiethnic Population
$522,976Gertraud Maskarinec · University Of Hawaii At Manoa · R25 · FY2008 · CA
Clinical production of viral vectors for cancer gene therapy
$522,901Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN): A Phase II Clinica
$522,886Lee Roy Morgan · Dekk-Tec, Inc. · R44 · FY2014 · CA
Objective decision support environment for clinical trials
$522,865Bradley J. Erickson · Mayo Clinic Rochester · U01 · FY2016 · CA
Objective decision support environment for clinical trials
$522,865Bradley J. Erickson · Mayo Clinic Rochester · U01 · FY2015 · CA
Networks Tools to Understand Sex- and Gender-Specific Drivers of Disease
$522,751Dawn L Demeo · Brigham And Women'S Hospital · R01 · FY2021 · HG
Project 2 Human Tumor Analysis
$522,720Sylvia Katina Plevritis · Stanford University · U54 · FY2023 · CA
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
$522,708Anton Wellstein · Georgetown University · R01 · FY2022 · CA
Mechanical regulation of the microenvironmental niche in skin tumorigenesis
$522,691Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA